Biotech CEOs are optimistic about 2016
01 June, 2016According to the 2016 Biotechnology Industry Position Survey of industry CEOs, biotechnology is front and centre of Australia's post-mining boom economic transition.
QBiotics presents its veterinary cancer compound
01 June, 2016QBiotics has outlined the latest clinical developments in cancer compound EBC-46 to an audience of veterinary cancer experts.
CSL celebrates dual FDA approvals
31 May, 2016CSL has received US FDA approval for two of the biotherapeutics company's products.
Peptides offer prospects for Alzheimer's treatment
30 May, 2016Biotech company Alzhyme has licensed a range of peptides, developed at the University of Tasmania, which have the potential to treat Alzheimer's disease.
AusCann and Murdoch Uni sign medical cannabis research alliance
25 May, 2016AusCann has announced a five-year research alliance with Murdoch University, intended to lead to the development of projects in the field of medicinal cannabis.
Biotron boasts anti-Zika drug compounds
23 May, 2016Shares in Biotron jumped 25% as the company announced that two compounds from its library have shown positive activity against Zika virus.
Australia's edge in early-phase clinical trials
20 May, 2016Cost, regulatory speed and flexibility and quality are the key drivers for biopharma companies selecting Australia for early-phase trials, according to a new report.
Diabetes monitoring through human sweat
19 May, 2016Korean scientists have created a wearable patch that allows accurate diabetes monitoring and feedback therapy by using human sweat.
Helping wrist fractures heal faster
17 May, 2016IPAS and Austofix have collaborated on the development the VRP 2.0 (Volar Radius Plate) — an innovative device that will help wrist fractures heal faster and can be fitted more easily by surgeons.
Enrolment completed in stem cell trial for osteoarthritis
16 May, 2016Regeneus has completed the enrolment of all 20 patients in its STEP trial — the first clinical trial of its allogeneic off-the-shelf MSC product for the treatment of knee osteoarthritis.
AusCann partners with world's largest legal cannabis company
09 May, 2016AusCann has announced a partnership agreement with Canada's Canopy Growth Corporation, the largest legal cannabis producer in the world.
Cell harvesting device treats burns and vitiligo
09 May, 2016Avita Medical's ReCell autologous cell harvesting device effectively reduces the occurrence of long-term scarring and itching symptoms associated with paediatric burn treatment and can also be used as a treatment for the skin condition vitiligo.
Patents and production announced for MSC product
06 May, 2016Cynata Therapeutics has had a busy week, announcing a successful patent for its Cymerus mesenchymal stem cell (MSC) technology, a patent application describing certain novel aspects of the technology and the manufacture of its clinical trial product.
Orthocell receives ethics approval for collagen scaffold study
04 May, 2016Orthocell has been granted ethical approval by St Vincent's Hospital Melbourne for a clinical study using its Celgro SMRT Grant collagen scaffold.
Clinical trials facility opens in Adelaide
02 May, 2016Pharmaceutical company IDT Australia has officially opened CMAX Adelaide, claimed to be Australia's largest and most contemporary early-phase clinical trial facility.
